Home/Filings/4/0001728117-22-000065
4//SEC Filing

Carter Laura 4

Accession 0001728117-22-000065

CIK 0001728117other

Filed

Jul 14, 8:00 PM ET

Accepted

Jul 15, 4:27 PM ET

Size

4.9 KB

Accession

0001728117-22-000065

Insider Transaction Report

Form 4
Period: 2022-07-15
Carter Laura
Chief Scientific Officer
Transactions
  • Purchase

    Common Stock

    2022-07-15$7.21/sh+6,934$49,99487,168 total
Footnotes (1)
  • [F1]The Reporting Person's purchase of common stock reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934, to the extent of 6,934 shares, with the Reporting Person's sale of 6,934 shares of common stock at a price ranging from $8.278 to $8.25 per share on July 1, 2022 and March 16, 2022. The Reporting Person paid to the Issuer $7,351.42, representing the full amount of the profit realized in connection with the short-swing transaction.

Issuer

Gossamer Bio, Inc.

CIK 0001728117

Entity typeother

Related Parties

1
  • filerCIK 0001858178

Filing Metadata

Form type
4
Filed
Jul 14, 8:00 PM ET
Accepted
Jul 15, 4:27 PM ET
Size
4.9 KB